Sanmun Duangmanee, Garwicz Daniel, Smith C I Edvard, Palmblad Jan, Fadeel Bengt
Division of Biochemical Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Br J Haematol. 2006 Sep;134(6):640-4. doi: 10.1111/j.1365-2141.2006.06240.x. Epub 2006 Aug 9.
Warts, hypogammaglobulinaemia, infections, myelokathexis (WHIM) syndrome is an inherited immune disorder associated with CXCR4 gene mutations. Recent studies suggested that impaired receptor downregulation and enhanced chemotactic responsiveness to stromal-derived factor-1 (SDF-1), the sole cognate ligand for CXCR4, may account for the characteristic features of WHIM patients. This study evaluated whether the interaction of SDF-1 with CXCR4 could block constitutive apoptosis of peripheral blood neutrophils from congenital neutropenia patients and controls. SDF-1 was found to be a potent anti-apoptotic factor for WHIM neutrophils harbouring a truncating CXCR4 mutation, but not for neutrophils from control individuals, thus supporting the notion that such mutations may confer enhanced functional responses.
疣、低丙种球蛋白血症、感染、髓细胞减少症(WHIM)综合征是一种与CXCR4基因突变相关的遗传性免疫疾病。最近的研究表明,受体下调受损以及对基质细胞衍生因子-1(SDF-1,CXCR4唯一的同源配体)的趋化反应增强,可能是WHIM患者特征的原因。本研究评估了SDF-1与CXCR4的相互作用是否能阻断先天性中性粒细胞减少症患者和对照组外周血中性粒细胞的组成性凋亡。结果发现,SDF-1是携带CXCR4截短突变的WHIM中性粒细胞的有效抗凋亡因子,但对对照组个体的中性粒细胞无效,从而支持了这种突变可能导致功能反应增强的观点。